Amanote Research
Register
Sign In
P2.01-109 Treatment Duration—A More Reasonable Definition to Evaluate the Efficacy of Crizotinib in ALK Positive Advanced NSCLC
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1164
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
G. Yang
D. Ma
J. Li
P. Xing
X. Hao
H. Xu
Y. Wang
Publisher
Elsevier BV